Premium
Proteasome Inhibitors with Photocontrolled Activity
Author(s) -
Hansen Mickel J.,
Velema Willem A.,
de Bruin Gerjan,
Overkleeft Herman S.,
Szymanski Wiktor,
Feringa Ben L.
Publication year - 2014
Publication title -
chembiochem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.05
H-Index - 126
eISSN - 1439-7633
pISSN - 1439-4227
DOI - 10.1002/cbic.201402237
Subject(s) - proteasome , cytotoxicity , moiety , chemistry , cytotoxic t cell , biochemistry , microbiology and biotechnology , cancer research , biology , stereochemistry , in vitro
Abstract Proteasome inhibitors are widely used in cancer treatment as chemotherapeutic agents. However, their employment often results in severe side effects, due to their non‐specific cytotoxicity towards healthy tissue. This problem might be overcome by using a photopharmacological approach, that is, by attaining external, dynamic, spatiotemporal photocontrol over the activity of a cytotoxic agent, achieved by the introduction of a photoswitchable moiety into its molecular structure. Here we describe the design, synthesis, and activity of photoswitchable proteasome inhibitors. Substantial differences in proteasome inhibitory activity in cell extracts were observed before and after irradiation with light. The presented results show potential for the development of chemotherapeutic agents that can be switched on and off with light, constituting a new strategy for spatiotemporally modulating proteasomal activity.